Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports

Share Article

Bernstein Liebhard LLP continues to evaluate transvaginal mesh lawsuits on behalf of women who suffered serious complications following surgery to treat pelvic organ prolapse or stress urinary incontinence.

Bernstein Liebhard LLP | Consumer Injury Lawyers
The increase in the use of vaginal mesh products during the period covered by the study is consistent with the introduction to the market of various transvaginal mesh kits for the treatment of pelvic organ prolapse.

As transvaginal mesh lawsuits continue to move forward in state and federal courts, a newly-published study has found that prolapse procedures that utilize vaginal mesh products rose significantly between 2005 and 2010, Bernstein Liebhard LLP reports. The study, published online November 19, 2012, in the American Journal of Obstetrics & Gynecology, drew on claims data to examine trends in vaginal mesh prolapse procedures (VMs), abdominal sacrocolpopexy (ASC), and minimally invasive sacrocolpopexy (MISC) from 2005 to 2010. Overall, 74.9% of the procedures performed during that time period were vaginal mesh surgeries, for an overall rate of 56.9 per 100,000 person-years.*

“The increase in the use of vaginal mesh products during the period covered by the study is consistent with the introduction to the market of various transvaginal mesh kits for the treatment of pelvic organ prolapse. In light of the recent regulatory advisories regarding transvaginal mesh devices, we do not believe this study reflects current trends,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The firm is currently evaluating potential lawsuits on behalf of women who suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to vaginal mesh.

Transvaginal Mesh Lawsuits
In July 2011, the U.S. Food & Drug Administration (FDA) warned that there had been a five-fold increase in reports of serious complications associated with the use of transvaginal mesh. The FDA also modified its previous position on the frequency of such complications, stating in the alert that vaginal mesh injuries associated with POP repair were not rare.**

Since the FDA advisory, a growing number of women have filed transvaginal mesh lawsuits alleging they experienced serious, painful and life-changing injuries following implantation of these devices to treat pelvic organ prolapse and stress urinary incontinence. Multidistrict litigations involving a number of manufacturers have been established in U.S. District Court, Southern District of West Virginia, including In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“ MDL No. 2327”). Consolidated litigations involving Johnson & Johnson Ethicon vaginal mesh products and C.R. Bard devices are also pending in New Jersey Superior Court ( In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10).

Bernstein Liebhard LLP partner, Jeffrey Grand, is serving on the Plaintiffs’ Steering Committees in all of the above federal litigations. In addition, Mr. Grand is serving as Co-Liason Counsel in both of the New Jersey Superior Court proceedings.

Women who suffered complications following implantation of transvaginal mesh may be entitled to compensation for their medical bills, pain and suffering, and other injuries. Bernstein Liebhard LLP is offering free lawsuit evaluations to any woman injured by vaginal mesh devices. A wealth of information regarding the firm's involvement with the ongoing pelvic mesh litigation can be found at Bernstein Liebhard's website, or call 1-877-779-1414 today.

*ajog.org/article/S0002-9378%2812%2902063-7/abstract
**fda.gov/medicaldevices/safety/alertsandnotices/ucm262435.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website